Evidence map›Paper›PMID 39913204›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

HflX-mediated drug resistance through ribosome splitting and rRNA disordering in mycobacteria.

Soneya Majumdar, Amuliya Kashyap, Ravi K Koripella, Manjuli R Sharma, Kelley Hurst-Hess, Swati R Manjari, Nilesh K Banavali, Pallavi Ghosh, Rajendra K Agrawal

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Ribosome hibernation in zinc-starvedMicrobiology spectrum · 2026
    Article
  2. Article
  3. Article
  4. Journal of bacteriology · 2026
    Review
  5. HflX mediates rifampicin resistance inFrontiers in microbiology · 2026
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Soneya MajumdarDivision of Translational Medicine, Wadsworth Center, New York State Department of Health, Albany, NY 12237.ORCID 0000-0002-6518-9057
Amuliya KashyapDivision of Genetics, Wadsworth Center, New York State Department of Health, Albany, NY 12208.
Ravi K KoripellaDivision of Translational Medicine, Wadsworth Center, New York State Department of Health, Albany, NY 12237.
Manjuli R SharmaDivision of Translational Medicine, Wadsworth Center, New York State Department of Health, Albany, NY 12237.ORCID 0000-0003-4821-748X
Kelley Hurst-HessDivision of Genetics, Wadsworth Center, New York State Department of Health, Albany, NY 12208.
Swati R ManjariDivision of Translational Medicine, Wadsworth Center, New York State Department of Health, Albany, NY 12237.
Nilesh K BanavaliDivision of Translational Medicine, Wadsworth Center, New York State Department of Health, Albany, NY 12237.ORCID 0000-0003-2206-7049
Pallavi GhoshDivision of Genetics, Wadsworth Center, New York State Department of Health, Albany, NY 12208.
Rajendra K AgrawalDivision of Translational Medicine, Wadsworth Center, New York State Department of Health, Albany, NY 12237.ORCID 0000-0001-9392-0065

Funding

Structural Aspects of Protein Synthesis in the Mammalian MitochondriaR01GM061576 · NIGMS · WADSWORTH CENTER · PI AGRAWAL, RAJENDRA K · 2001 to 2018
$6.4M
Alternative Ribosomes & Antibiotic Tolerance in MycobacteriaR01AI132422 · NIAID · WADSWORTH CENTER · PI RAJENDRA K AGRAWAL, Anil Kumar Ojha · 2017 to 2026
$3.8M
Role of ribosome modulating proteins in conferring Mycobacterium abscessus antibiotic resistanceR01AI155473 · NIAID · WADSWORTH CENTER · PI GHOSH, PALLAVI · 2020 to 2024
$2.4M
Systematic Discovery and Analysis of Small Proteins and Small ORFs in MycobacteriaR01GM139277 · NIGMS · WADSWORTH CENTER · PI DERBYSHIRE, KEITH M, GRAY, TODD · 2020 to 2023
$2.2M
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI132422HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) Al155473HHS | NIH | National Institute of General Medical Sciences (NIGMS) GM61576NIAID NIH HHS R01 AI132422NIAID NIH HHS R01 AI155473NIGMS NIH HHS R01 GM061576NIGMS NIH HHS R01 GM139277
6 · The paper itself

Abstract

HflX is a highly conserved ribosome-associated GTPase implicated in rescuing stalled ribosomes and mediating antibiotic resistance in several bacteria, including macrolide-lincosamide antibiotic resistance in mycobacteria. Mycobacterial HflXs carry a distinct N-terminal extension (NTE) and a small insertion, as compared to their eubacterial homologs. Here, we present several high-resolution cryo-EM structures of mycobacterial HflX in complex with the 70S ribosome and its 50S subunit, with and without antibiotics. These structures reveal a distinct mechanism for HflX-mediated ribosome splitting and antibiotic resistance in mycobacteria. Our findings indicate that the NTE of mycobacterial HflX induces persistent disordering of multiple 23S rRNA helices, facilitating the dissociation of the 70S ribosome and generating an inactive pool of 50S subunits. During this process, HflX undergoes a large conformational change that stabilizes its NTE. Mycobacterial HflX also acts as an anti-association factor by binding to predissociated 50S subunits. Our structures show that a mycobacteria-specific insertion in HflX reaches far into the peptidyl transferase center (PTC), such that it would overlap with the ribosome-bound macrolide antibiotics. However, in the presence of antibiotics, this insertion retracts, adjusts around, and interacts with the antibiotic molecules. These results suggest that mycobacterial HflX is agnostic to antibiotic presence in the PTC. It mediates antibiotic resistance by splitting antibiotic-stalled 70S ribosomes and inactivating the resulting 50S subunits.

Indexed as

Bacterial ProteinsDrug Resistance, BacterialMycobacteriumRibosomesRNA, RibosomalAnti-Bacterial AgentsCryoelectron MicroscopyMacrolidesRNA, Ribosomal, 23SAnti-Bacterial AgentsBacterial ProteinsMacrolidesRNA, RibosomalRNA, Ribosomal, 23S50S subunit inactivationantibiotic resistancecryo-EMmycobacterial HflXstructure of mycobacterial ribosome-HflX complex

Identifiers

PMID39913204
PMCPMC11831132

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.